These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32947174)

  • 21. Initiation into heroin use among street-involved youth in a Canadian setting: A longitudinal cohort study.
    Goldman-Hasbun J; Kerr T; Nosova E; Shulha H; Wood E; DeBeck K
    Drug Alcohol Depend; 2019 Dec; 205():107579. PubMed ID: 31600619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria.
    Abadie R; Cano M; Habecker P; Gelpí-Acosta C
    Harm Reduct J; 2022 Nov; 19(1):129. PubMed ID: 36424666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance.
    Stopka TJ; Jacque E; Kelso P; Guhn-Knight H; Nolte K; Hoskinson R; Jones A; Harding J; Drew A; VanDonsel A; Friedmann PD
    Prev Med; 2019 Nov; 128():105740. PubMed ID: 31158400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014.
    Chatterjee A; Larochelle MR; Xuan Z; Wang N; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY; Bagley SM
    Drug Alcohol Depend; 2019 Jan; 194():28-31. PubMed ID: 30391835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.
    Rieb LM; DeBeck K; Hayashi K; Wood E; Nosova E; Milloy MJ
    Drug Alcohol Depend; 2020 Nov; 216():108242. PubMed ID: 32861135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription opioid use and non-fatal overdose in a cohort of injection drug users.
    Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T
    Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived Causes of Personal versus Witnessed Overdoses among People who Inject Opioids.
    Behar E; Chang JS; Countess K; Matheson T; Santos GM; Coffin P
    Subst Use Misuse; 2019; 54(12):1929-1937. PubMed ID: 31070106
    [No Abstract]   [Full Text] [Related]  

  • 29. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
    Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
    Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription opioid misuse among African-American adults: A rural-urban comparison of prevalence and risk.
    Rigg KK; Nicholson HL
    Drug Alcohol Depend; 2019 Apr; 197():191-196. PubMed ID: 30844615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.
    Ambekar A; Rao R; Mishra AK; Agrawal A
    Drug Alcohol Rev; 2015 Jan; 34(1):97-104. PubMed ID: 25302827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends and key correlates of prescription opioid injection misuse in the United States.
    Jones CM
    Addict Behav; 2018 Mar; 78():145-152. PubMed ID: 29175290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuse.
    Paulozzi LJ; Zhou C; Jones CM; Xu L; Florence CS
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):545-52. PubMed ID: 26861165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rural communities face more than an opioid crisis: Reimagining funding assistance to address polysubstance use, associated health problems, and limited rural service capacity.
    Carpenedo Mun C; Schuler H; Baker R; Byrne F; Bresani E; Meyers K
    J Rural Health; 2023 Sep; 39(4):795-803. PubMed ID: 36775905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.
    Mars S; Ondocsin J; Holm N; Ciccarone D
    Harm Reduct J; 2024 Mar; 21(1):57. PubMed ID: 38443903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing an Updated "Break the Cycle" Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US "opioid epidemic" Setting.
    Des Jarlais D; Uuskula A; Talu A; Barnes DM; Raag M; Arasteh K; Org G; Demarest D; Feelemyer J; Berg H; Tross S
    AIDS Behav; 2019 Sep; 23(9):2304-2314. PubMed ID: 30879209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.
    Palmer A; Scott N; Dietze P; Higgs P
    Harm Reduct J; 2020 Feb; 17(1):14. PubMed ID: 32106854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.
    Cochran GT; Engel RJ; Hruschak VJ; Tarter RE
    J Pharm Pract; 2017 Oct; 30(5):498-505. PubMed ID: 27402634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing Opioid Withdrawal Experiences and Consequences Among a Community Sample of People Who Use Opioids.
    Simpson KA; Bolshakova M; Kirkpatrick MG; Davis JP; Cho J; Barrington-Trimis J; Kral AH; Bluthenthal RN
    Subst Use Misuse; 2024; 59(6):886-894. PubMed ID: 38287506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.